Cargando…

The role of glucose lowering agents on restenosis after percutaneous coronary intervention in patients with diabetes mellitus

INTRODUCTION: The prevalence of diabetes is increasing rapidly, and individuals with diabetes are at high risk for cardiovascular disorders. Subsequently the percentage of patients with diabetes subjected to revascularisation, i.e. either percutaneous coronary intervention (PCI) or coronary artery b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lexis, Chris PH, Rahel, Braim M, Meeder, Joan G, Zijlstra, Felix, van der Horst, Iwan CC
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2727510/ https://www.ncbi.nlm.nih.gov/pubmed/19635170 http://dx.doi.org/10.1186/1475-2840-8-41

Ejemplares similares

Glucose–insulin–potassium infusion in sepsis and septic shock: no hard evidence yet
por: van der Horst, Iwan CC, et al.
Publicado: (2003)

Non-cardiac chest pain: prognosis and secondary healthcare utilisation
por: Mol, Karen Anne, et al.
Publicado: (2018)

In stent restenosis after percutaneous coronary intervention
por: Eyüboğlu, Mehmet
Publicado: (2016)

Successful surgical excision of primary right atrial angiosarcoma
por: Bouma, Wobbe, et al.
Publicado: (2011)

The impact of a reduced dose of dexamethasone on glucose control after coronary artery bypass surgery
por: Vogelzang, Mathijs, et al.
Publicado: (2007)

New predictors of in-stent restenosis in patients with diabetes mellitus undergoing percutaneous coronary intervention with drug-eluting stent
por: Wang, Jian-Long, et al.
Publicado: (2018)

Impact of anemia on in-stent restenosis after percutaneous coronary intervention
por: Hu, Huilin, et al.
Publicado: (2021)

Triglyceride-glucose index for predicting repeat revascularization and in-stent restenosis in patients with chronic coronary syndrome undergoing percutaneous coronary intervention
por: Guo, Xuantong, et al.
Publicado: (2023)

Persistent hyperglycemia is an independent predictor of outcome in acute myocardial infarction
por: van der Horst, Iwan CC, et al.
Publicado: (2007)

The importance of left ventricular function for long-term outcome after primary percutaneous coronary intervention
por: van der Vleuten, Pieter A, et al.
Publicado: (2008)

Factors Affecting In-stent Restenosis in Patients Undergoing Percutaneous Coronary Angioplasty
por: Sajadian, Mostafa, et al.
Publicado: (2018)

The first year of the Venlo percutaneous coronary intervention program: procedural and 6-month clinical outcomes
por: Mol, K. A., et al.
Publicado: (2013)

Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents
por: Zhu, Yong, et al.
Publicado: (2021)

Coronary restenosis
Publicado: (1993)

Coronary collaterals and risk for restenosis after percutaneous coronary interventions: a meta-analysis
por: Meier, Pascal, et al.
Publicado: (2012)

Genetic risk factors for restenosis after percutaneous coronary intervention in Kazakh population
por: Zholdybayeva, Elena V., et al.
Publicado: (2016)

Impact of hyperuricemia on clinical outcomes after percutaneous coronary intervention for in-stent restenosis
por: Joo, Hyung Joon, et al.
Publicado: (2018)

An analysis of factors related to the development of in-stent restenosis after percutaneous coronary intervention
por: Zhang, Gai, et al.
Publicado: (2020)

Risk factors associated with intra-stent restenosis after percutaneous coronary intervention
por: Alexandrescu, Dan-Mihai, et al.
Publicado: (2021)

Predictors of restenosis following percutaneous coronary stent implantation: The role of trimetazidine therapy
por: Csató, Gábor, et al.
Publicado: (2022)

In-stent restenosis after percutaneous coronary intervention: emerging knowledge on biological pathways
por: Pelliccia, Francesco, et al.
Publicado: (2023)

Restenosis After Percutaneous Angioplasty: The Role of Vascular Inflammation
por: Schillinger, Martin, et al.
Publicado: (2005)

Risk factors of in-stent restenosis in patients with diabetes mellitus after percutaneous coronary intervention: A protocol for systematic review and meta-analysis
por: Li, Suiping, et al.
Publicado: (2021)

Predictive Value of COPD History on In-Stent Restenosis in Coronary Arteries Following Percutaneous Coronary Intervention
por: Hou, Ling, et al.
Publicado: (2023)

Platelet Distribution Width on Admission Predicts In-Stent Restenosis in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus Treated with Percutaneous Coronary Intervention
por: Hu, Cheng-Ping, et al.
Publicado: (2018)

Calculating the overall risk of within-stent restenosis after multilesion percutaneous coronary intervention
por: Parviz, Yasir, et al.
Publicado: (2013)

The number of stents was an independent risk of stent restenosis in patients undergoing percutaneous coronary intervention
por: Tang, Long, et al.
Publicado: (2019)

An analysis of factors related to the development of in-stent restenosis after percutaneous coronary intervention: Retraction
Publicado: (2020)

Serum Homocysteine Level Predictive Capability for Severity of Restenosis Post Percutaneous Coronary Intervention
por: Guo, Jiqiang, et al.
Publicado: (2022)

Hyperglycaemic index as a tool to assess glucose control: a retrospective study
por: Vogelzang, Mathijs, et al.
Publicado: (2004)

Systematic Review of Chinese Herbal Medicines for Preventing in-Stent Coronary Restenosis after Percutaneous Coronary Intervention
por: Zheng, Guo-Hua, et al.
Publicado: (2012)

Arterial stiffness in patients with coronary artery disease: relation with in-stent restenosis following percutaneous coronary intervention
por: Prskalo, Zrinko, et al.
Publicado: (2016)

Correlation between estimated glucose disposal rate and in-stent restenosis following percutaneous coronary intervention in individuals with non-ST-segment elevation acute coronary syndrome
por: Liu, Chi, et al.
Publicado: (2022)

Diabetes Mellitus and Glucose as Predictors of Mortality in Primary Coronary Percutaneous Intervention
por: David, Renato Budzyn, et al.
Publicado: (2014)

The Predictive Value of ΣΔST/ΔHR Index for Restenosis after Percutaneous Coronary Intervention
por: Kim, Chul, et al.
Publicado: (2012)

Variation in the human soluble epoxide hydrolase gene and risk of restenosis after percutaneous coronary intervention
por: Kullmann, Silke, et al.
Publicado: (2009)

Effects of Probucol on Restenosis after Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis
por: Liu, Jichen, et al.
Publicado: (2015)

Albumin to globulin ratio was associated with in‐stent restenosis and revascularization events after percutaneous coronary intervention
por: Zhang, Rui, et al.
Publicado: (2022)

Ruling out acute coronary syndrome in primary care with a clinical decision rule and a capillary, high-sensitive troponin I point of care test: study protocol of a diagnostic RCT in the Netherlands (POB HELP)
por: van den Bulk, Simone, et al.
Publicado: (2023)

Accuracy and feasibility of point-of-care and continuous blood glucose analysis in critically ill ICU patients
por: Corstjens, Anouk M, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_ti5t2ullddnfcrj2fc7uvkiheg